Cte Group Spolka Akcyjna Logo

Cte Group Spolka Akcyjna

Diversified firm in HR services, corporate events, and composite materials.

LPS | WAR

Overview

Corporate Details

ISIN(s):
PLLRPSP00015 (+4 more)
LEI:
259400L72C5LYIFMI528
Country:
Poland
Address:
CHORZÓW 75 PUŁKU PIECHOTY 1, 41-500 CHORZÓW

Description

Cte Group Spolka Akcyjna is a diversified company, formerly known as Lauren Peso Polska S.A., operating across three distinct business segments. The first division provides corporate training, HR consulting, and competency development services, emphasizing a tailored, dialogue-based approach. The second segment specializes in organizing unique corporate events, focusing on team-building and integration activities. The third division is dedicated to the design and production of advanced composite materials. These innovative materials are characterized by their light weight and high durability, finding applications in the manufacturing of medical devices and components designed for use in aggressive environments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-05-29 06:39
Śródroczne skrócone skonsolidowane sprawozdanie finansowe za 1 kw. 2023
Polish 8.3 MB
2023-04-28 18:06
Oświadczenie Zarządu
Polish 10.5 KB
2023-04-28 18:06
Oświadczenie Zarządu
Polish 276.4 KB
2023-04-28 18:06
Opinia biegłego rewidenta do SSF 2022
Polish 5.5 KB
2023-04-28 18:06
Opinia biegłego rewidenta do SSF 2022
Polish 3.5 MB
2023-04-28 18:06
Sprawozdanie Zarzadu z działalności 2022
Polish 10.5 KB
2023-04-28 18:06
Sprawozdanie Zarządu z działalności 2022
Polish 17.4 MB
2023-04-28 18:06
SSF 2022
Polish 21.2 KB
2023-04-28 18:06
SSF 2022
Polish 7.9 MB
2023-04-28 18:06
List do Akcjonariuszy
Polish 10.5 KB
2023-04-28 18:06
List do Akcjonariuszy
Polish 97.6 KB
2023-04-28 18:02
Oświadczenie Zarządu
Polish 10.5 KB
2023-04-28 18:02
Oświadczenie Zarządu
Polish 271.3 KB
2023-04-28 18:02
List do Akcjonariuszy
Polish 10.5 KB
2023-04-28 18:02
List do Akcjonariuszy
Polish 97.6 KB

Automate Your Workflow. Get a real-time feed of all Cte Group Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cte Group Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cte Group Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.